What is Carbohydrate Antigen 125 (CA 125)?
Carbohydrate Antigen 125 (CA 125) is a commonly encountered glycoprotein biomarker in clinical practice and the most extensively studied tumor marker for ovarian cancer. It also demonstrates elevated levels—albeit to varying degrees—in other malignancies, including epithelial ovarian cancer, cervical cancer, uterine corpus cancer, endometrial cancer, pancreatic cancer, lung cancer, gastric cancer, colorectal cancer, and breast cancer. So, what exactly is Carbohydrate Antigen 125? The following section provides a detailed explanation.
What Is Carbohydrate Antigen 125?
Carbohydrate Antigen 125 refers to CA 125—not CA 15, as incorrectly stated in the original text. CA 125 is associated with cellular metabolism in tumor cells. Elevated CA 125 levels are primarily indicative of several pathological conditions, with malignancy being the most common cause.

First, gastrointestinal malignancies—including gastric cancer, colorectal cancer, and even hepatocellular carcinoma—may present with elevated CA 125 levels.
Second, gynecological malignancies—particularly ovarian cancer—are strongly associated with increased CA 125 concentrations.
Third, elevated CA 125 may also occur in patients with inflammatory conditions, especially during acute inflammation or in those with pleural or ascitic effusions. Although these patients lack malignant cells, CA 125 elevation can still occur. With appropriate anti-infective therapy and serial follow-up testing, CA 125 levels in such cases typically decline to normal ranges.
Therefore, upon detection of elevated CA 125, patients should actively pursue diagnostic evaluation to identify the underlying cause. In some instances, this may reveal a previously undiagnosed malignancy, enabling timely and appropriate therapeutic intervention.
We hope the above information is helpful to you.